Kun‐Yu Teng

1.2k total citations
25 papers, 967 citations indexed

About

Kun‐Yu Teng is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Kun‐Yu Teng has authored 25 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Kun‐Yu Teng's work include Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (6 papers) and MicroRNA in disease regulation (5 papers). Kun‐Yu Teng is often cited by papers focused on Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (6 papers) and MicroRNA in disease regulation (5 papers). Kun‐Yu Teng collaborates with scholars based in United States, China and Taiwan. Kun‐Yu Teng's co-authors include Kalpana Ghoshal, Michael A. Caligiuri, Jianhua Yu, Anthony G. Mansour, Charles L. Shapiro, Jianying Zhang, Ting Lu, Bhuvaneswari Ramaswamy, Yuanzhi Lu and Sarmila Majumder and has published in prestigious journals such as Nature Communications, Molecular Cell and The Journal of Immunology.

In The Last Decade

Kun‐Yu Teng

25 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun‐Yu Teng United States 14 442 436 329 204 106 25 967
Galina M. Kiriakova United States 10 310 0.7× 380 0.9× 169 0.5× 210 1.0× 48 0.5× 11 707
Petros A. Tyrakis United Kingdom 9 299 0.7× 540 1.2× 483 1.5× 430 2.1× 98 0.9× 11 1.2k
Samuel Wormald Australia 7 408 0.9× 369 0.8× 269 0.8× 141 0.7× 54 0.5× 8 802
Pia Herrmann Germany 18 443 1.0× 665 1.5× 175 0.5× 236 1.2× 41 0.4× 31 1.1k
Haihua Qian China 17 261 0.6× 500 1.1× 140 0.4× 311 1.5× 41 0.4× 29 828
Akio Yamasaki Japan 15 523 1.2× 477 1.1× 391 1.2× 220 1.1× 41 0.4× 37 1.1k
Sailan Zou China 9 348 0.8× 561 1.3× 226 0.7× 259 1.3× 35 0.3× 11 1.0k
Yumi Yokoyama United States 16 309 0.7× 729 1.7× 186 0.6× 379 1.9× 82 0.8× 36 1.1k
Jufeng Guo China 17 204 0.5× 373 0.9× 154 0.5× 202 1.0× 52 0.5× 33 673
Şerif Şentürk Türkiye 16 295 0.7× 796 1.8× 122 0.4× 246 1.2× 66 0.6× 38 1.2k

Countries citing papers authored by Kun‐Yu Teng

Since Specialization
Citations

This map shows the geographic impact of Kun‐Yu Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun‐Yu Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun‐Yu Teng more than expected).

Fields of papers citing papers by Kun‐Yu Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun‐Yu Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun‐Yu Teng. The network helps show where Kun‐Yu Teng may publish in the future.

Co-authorship network of co-authors of Kun‐Yu Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Kun‐Yu Teng. A scholar is included among the top collaborators of Kun‐Yu Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun‐Yu Teng. Kun‐Yu Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Ting, Anthony G. Mansour, Shoubao Ma, et al.. (2024). Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer. Cancer Immunology Research. 12(6). 731–743. 7 indexed citations
2.
Mansour, Anthony G., Kun‐Yu Teng, Zheng Zhu, et al.. (2023). Off-the-shelf CAR–engineered natural killer cells targeting FLT3 enhance killing of acute myeloid leukemia. Blood Advances. 7(20). 6225–6239. 27 indexed citations
3.
Lu, Ting, Rui Ma, Wenjuan Dong, et al.. (2022). Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19. Nature Communications. 13(1). 2576–2576. 39 indexed citations
4.
Teng, Kun‐Yu, Anthony G. Mansour, Zheng Zhu, et al.. (2022). Off-the-Shelf Prostate Stem Cell Antigen–Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer. Gastroenterology. 162(4). 1319–1333. 95 indexed citations
5.
Ma, Rui, Ting Lu, Zhenlong Li, et al.. (2021). An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma. Cancer Research. 81(13). 3635–3648. 162 indexed citations
6.
Lu, Ting, Rui Ma, Zhenlong Li, et al.. (2021). Hijacking TYRO3 from Tumor Cells via Trogocytosis Enhances NK-cell Effector Functions and Proliferation. Cancer Immunology Research. 9(10). 1229–1241. 24 indexed citations
7.
Lu, Ting, Li Chen, Anthony G. Mansour, et al.. (2021). Cbl-b Is Upregulated and Plays a Negative Role in Activated Human NK Cells. The Journal of Immunology. 206(4). 677–685. 9 indexed citations
8.
Cassel, Teresa, Kun‐Yu Teng, Peng Hu, et al.. (2020). Regulation of hepatic glutamine metabolism by miR-122. Molecular Metabolism. 34. 174–186. 43 indexed citations
9.
Wani, Nissar Ahmad, Bo Zhang, Kun‐Yu Teng, et al.. (2018). Reprogramming of Glucose Metabolism by Zerumbone Suppresses Hepatocarcinogenesis. Molecular Cancer Research. 16(2). 256–268. 32 indexed citations
10.
Rudolph, Marion, Steven T. Sizemore, Yuanzhi Lu, et al.. (2018). A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer. Breast Cancer Research and Treatment. 169(3). 457–467. 7 indexed citations
11.
Teng, Kun‐Yu. (2017). Molecular mechanisms underlying microRNA-122 mediated suppression of liver inflammation, fibrosis, and carcinogenesis. OhioLink ETD Center (Ohio Library and Information Network). 1 indexed citations
12.
Luna, Joseph M., Juan M. Barajas, Kun‐Yu Teng, et al.. (2017). Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer. Molecular Cell. 67(3). 400–410.e7. 68 indexed citations
13.
Teng, Kun‐Yu, Jianfeng Han, Jianhua Yu, & Kalpana Ghoshal. (2017). Blocking the CCL2‐CCR2 Axis Using CCL2 Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model. The FASEB Journal. 31(S1). 3 indexed citations
14.
Teng, Kun‐Yu, Jianfeng Han, Xiaoli Zhang, et al.. (2016). Blocking the CCL2–CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model. Molecular Cancer Therapeutics. 16(2). 312–322. 103 indexed citations
15.
Hsu, Shu‐Hao, Evan R. Delgado, P. Anthony Otero, et al.. (2016). MicroRNA‐122 regulates polyploidization in the murine liver. Hepatology. 64(2). 599–615. 66 indexed citations
16.
Teng, Kun‐Yu & Kalpana Ghoshal. (2015). Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis. Gene Expression. 16(4). 155–162. 39 indexed citations
17.
Ramaswamy, Bhuvaneswari, Yuanzhi Lu, Kun‐Yu Teng, et al.. (2012). Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway. Cancer Research. 72(19). 5048–5059. 162 indexed citations
18.
Peng, Zhengang, Rulong Shen, Yingwei Li, et al.. (2012). Epigenetic Repression of RARRES1 Is Mediated by Methylation of a Proximal Promoter and a Loss of CTCF Binding. PLoS ONE. 7(5). e36891–e36891. 17 indexed citations
19.
Majumder, Sarmila, Yuanzhi Lu, Kun‐Yu Teng, et al.. (2012). Abstract 5606: Hedgehog pathway is a novel therapeutic target in tamoxifen resistant breast cancer that protects from autophagic cell death and is aberrantly activated by PI3K/AKT signaling. Cancer Research. 72(8_Supplement). 5606–5606. 1 indexed citations
20.
Liu, Chung‐Jung, Chia‐Hua Kuo, Hong Chen, et al.. (2010). Garlic Oil Alleviates MAPKs‐ and IL‐6‐mediated Diabetes‐related Cardiac Hypertrophy in STZ‐induced DM Rats. Evidence-based Complementary and Alternative Medicine. 2011(1). 950150–950150. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026